HEALTHWKRN ABC NASHVILLE
FDA approves gene therapy for children with sickle cell disease ages 2+
The FDA approved gene therapy for treating sickle cell disease in children aged 2 and older. A Nashville doctor described the approval as a medical milestone.
Related Signal
Adjacent reporting
- Gene therapy for children with sickle cell disease approved by FDA
- ‘A leap of faith’: Nashville teen makes history with gene-editing treatment for sickle cell disease
- 23-year-old becomes first in state functionally cured of sickle cell disease
- 23-year-old becomes first in state functionally cured of sickle cell disease
- 23-year-old becomes first in state functionally cured of sickle cell disease
- Groundbreaking research led in Nashville could change sickle cell treatment for children